(RTTNews) – BioSyent Inc. (RX.V) has reported a significant increase in profit for its second quarter, reflecting strong financial performance compared to the same period last year.
The company’s earnings reached C$2.85 million, or C$0.245 per share, compared to C$2.02 million, or C$0.176 per share, in the prior-year quarter.
Revenue for the period surged 95.2% to C$19.87 million from C$10.18 million year-over-year, demonstrating robust growth in the company’s core operations.
Also Read
- Pakistan’s ports get war-time windfall amid shifting Gulf shipping routes
- Hong Kong Tiananmen activists found guilty of national security charges
- From Netflix Deal to Downscaled Arrangements: The Tumultuous Path of Harry and Meghan’s U.S. Media Ventures
- MDxHealth’s Strategic Pivot Post-ExoDx Acquisition Fuels 16% YOY Revenue Growth Amid Q2 2026 Results
